X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-05-14 | RXRX | Borgeson Blake | Dir | S - Sale | $10.12 | -20,054 | 7,198,360 | 0% | -$202,934 | ||||||
| DM | 2024-05-01 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $8.10 | -100,000 | 834,820 | -11% | -$810,000 | |||||
2024-04-30 | RXRX | Borgeson Blake | Dir | S - Sale | $7.95 | -11,447 | 7,218,414 | 0% | -$90,964 | ||||||
| D | 2024-04-25 | RXRX | Marriott Tina | Pres, COO | M - OptEx | $1.06 | +3,000 | 543,231 | +1% | +$3,180 | |||||
| D | 2024-04-25 | RXRX | Marriott Tina | Pres, COO | S - Sale+OE | $7.67 | -3,000 | 543,231 | -1% | -$23,021 | |||||
2024-04-16 | RXRX | Borgeson Blake | Dir | S - Sale | $7.66 | -11,447 | 7,229,861 | 0% | -$87,725 | ||||||
| DM | 2024-04-16 | RXRX | Secora Michael | CFO | M - OptEx | $2.22 | +75,000 | 1,231,055 | +6% | +$166,500 | |||||
| DM | 2024-04-16 | RXRX | Secora Michael | CFO | S - Sale+OE | $7.63 | -48,124 | 1,231,055 | -4% | -$367,007 | |||||
| DM | 2024-04-03 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $8.93 | -130,000 | 938,524 | -12% | -$1,160,900 | |||||
2024-04-02 | RXRX | Borgeson Blake | Dir | S - Sale | $8.82 | -11,447 | 7,241,308 | 0% | -$100,942 | ||||||
| D | 2024-03-28 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $10.10 | -65,000 | 1,043,524 | -6% | -$656,500 | |||||
| D | 2024-03-21 | RXRX | Marriott Tina | Pres, COO | M - OptEx | $1.06 | +8,000 | 639,982 | +1% | +$8,480 | |||||
| D | 2024-03-21 | RXRX | Marriott Tina | Pres, COO | S - Sale+OE | $10.75 | -8,000 | 639,982 | -1% | -$85,980 | |||||
2024-03-19 | RXRX | Borgeson Blake | Dir | S - Sale | $10.79 | -20,054 | 7,252,755 | 0% | -$216,423 | ||||||
| DM | 2024-03-12 | RXRX | Secora Michael | CFO | M - OptEx | $2.22 | +75,000 | 1,204,179 | +7% | +$166,500 | |||||
| DM | 2024-03-12 | RXRX | Secora Michael | CFO | S - Sale+OE | $10.74 | -50,000 | 1,204,179 | -4% | -$537,190 | |||||
| D | 2024-03-06 | RXRX | Gibson Christopher | CEO | M - OptEx | $4.42 | +39,924 | 1,108,524 | +4% | +$176,384 | |||||
| D | 2024-03-06 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $11.73 | -61,319 | 1,108,524 | -5% | -$719,505 | |||||
2024-03-05 | RXRX | Borgeson Blake | Dir | S - Sale | $12.06 | -20,054 | 7,272,809 | 0% | -$241,805 | ||||||
| D | 2024-02-22 | RXRX | Marriott Tina | Pres, COO | M - OptEx | $1.06 | +8,000 | 639,982 | +1% | +$8,480 | |||||
| D | 2024-02-22 | RXRX | Marriott Tina | Pres, COO | S - Sale+OE | $14.90 | -8,000 | 639,982 | -1% | -$119,160 | |||||
2024-02-20 | RXRX | Borgeson Blake | Dir | S - Sale | $12.32 | -20,054 | 7,292,863 | 0% | -$247,125 | ||||||
| DM | 2024-02-13 | RXRX | Secora Michael | CFO | M - OptEx | $2.22 | +75,000 | 1,186,351 | +7% | +$166,500 | |||||
| DM | 2024-02-13 | RXRX | Secora Michael | CFO | S - Sale+OE | $10.16 | -50,000 | 1,186,351 | -4% | -$507,985 | |||||
| D | 2024-02-07 | RXRX | Gibson Christopher | CEO | M - OptEx | $2.48 | +31,250 | 774,703 | +4% | +$77,500 | |||||
| D | 2024-02-07 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $9.22 | -48,272 | 774,703 | -6% | -$444,981 | |||||
2024-02-06 | RXRX | Borgeson Blake | Dir | S - Sale | $9.30 | -11,447 | 7,312,917 | 0% | -$106,489 | ||||||
| D | 2024-01-25 | RXRX | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +8,000 | 414,548 | +2% | +$8,480 | |||||
| D | 2024-01-25 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale+OE | $10.35 | -8,000 | 414,548 | -2% | -$82,762 | |||||
2024-01-23 | RXRX | Borgeson Blake | Dir | S - Sale | $10.58 | -20,054 | 7,324,364 | 0% | -$212,083 | ||||||
| D | 2024-01-16 | RXRX | Virani Shafique | Chief Business Officer | M - OptEx | $2.22 | +18,000 | 136,748 | +15% | +$39,960 | |||||
| D | 2024-01-16 | RXRX | Virani Shafique | Chief Business Officer | S - Sale+OE | $10.93 | -18,000 | 136,748 | -12% | -$196,740 | |||||
| DM | 2024-01-16 | RXRX | Secora Michael | CFO | M - OptEx | $2.22 | +75,000 | 981,014 | +8% | +$166,500 | |||||
| DM | 2024-01-16 | RXRX | Secora Michael | CFO | S - Sale+OE | $10.35 | -50,000 | 981,014 | -5% | -$517,508 | |||||
2024-01-09 | RXRX | Li Dean Y | Dir | S - Sale | $13.66 | -29,000 | 3,170,666 | -1% | -$396,214 | ||||||
2024-01-09 | RXRX | Borgeson Blake | Dir | S - Sale | $13.62 | -20,054 | 7,344,418 | 0% | -$273,202 | ||||||
| D | 2024-01-03 | RXRX | Gibson Christopher | CEO | M - OptEx | $2.48 | +31,250 | 791,725 | +4% | +$77,500 | |||||
| D | 2024-01-03 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $9.50 | -55,853 | 791,725 | -7% | -$530,567 | |||||
| D | 2023-12-28 | RXRX | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +8,000 | 414,548 | +2% | +$8,480 | |||||
| D | 2023-12-28 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale+OE | $10.58 | -8,000 | 414,548 | -2% | -$84,654 | |||||
2023-12-26 | RXRX | Borgeson Blake | Dir | S - Sale | $10.63 | -20,054 | 7,364,472 | 0% | -$213,144 | ||||||
| D | 2023-12-15 | RXRX | Virani Shafique | Chief Business Officer | M - OptEx | $2.22 | +18,000 | 136,748 | +15% | +$39,960 | |||||
| D | 2023-12-15 | RXRX | Virani Shafique | Chief Business Officer | S - Sale+OE | $9.60 | -18,000 | 136,748 | -12% | -$172,800 | |||||
2023-12-14 | RXRX | Dar Zavain | Dir | S - Sale | $9.00 | -20,141 | 53,823 | -27% | -$181,269 | ||||||
| DM | 2023-12-12 | RXRX | Secora Michael | CFO | M - OptEx | $2.22 | +75,000 | 956,014 | +9% | +$166,500 | |||||
| DM | 2023-12-12 | RXRX | Secora Michael | CFO | S - Sale+OE | $7.49 | -50,000 | 956,014 | -5% | -$374,638 | |||||
2023-12-12 | RXRX | Borgeson Blake | Dir | S - Sale | $7.40 | -11,447 | 7,384,526 | 0% | -$84,693 | ||||||
| D | 2023-12-06 | RXRX | Gibson Christopher | CEO | M - OptEx | $2.48 | +31,250 | 791,328 | +4% | +$77,500 | |||||
| D | 2023-12-06 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $7.49 | -59,829 | 791,328 | -7% | -$448,394 | |||||
2023-11-28 | RXRX | Borgeson Blake | Dir | S - Sale | $6.72 | -11,447 | 7,395,973 | 0% | -$76,918 | ||||||
| D | 2023-11-16 | RXRX | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +3,000 | 413,404 | +1% | +$3,180 | |||||
| D | 2023-11-16 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale+OE | $6.76 | -3,000 | 413,404 | -1% | -$20,280 | |||||
| D | 2023-11-15 | RXRX | Virani Shafique | Chief Business Officer | M - OptEx | $2.22 | +18,000 | 136,748 | +15% | +$39,960 | |||||
| D | 2023-11-15 | RXRX | Virani Shafique | Chief Business Officer | S - Sale+OE | $6.51 | -18,000 | 136,748 | -12% | -$117,180 | |||||
2023-11-14 | RXRX | Borgeson Blake | Dir | S - Sale | $6.32 | -8,885 | 7,407,420 | 0% | -$56,151 | ||||||
| DM | 2023-11-14 | RXRX | Secora Michael | CFO | M - OptEx | $2.22 | +75,000 | 931,014 | +9% | +$166,500 | |||||
| DM | 2023-11-14 | RXRX | Secora Michael | CFO | S - Sale+OE | $6.82 | -50,000 | 931,014 | -5% | -$340,929 | |||||
| D | 2023-11-01 | RXRX | Gibson Christopher | CEO | M - OptEx | $2.48 | +31,250 | 836,820 | +4% | +$77,500 | |||||
| D | 2023-11-01 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $5.17 | -62,177 | 836,820 | -7% | -$321,301 | |||||
2023-10-31 | RXRX | Borgeson Blake | Dir | S - Sale | $5.27 | -8,885 | 7,416,305 | 0% | -$46,864 | ||||||
| D | 2023-10-26 | RXRX | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +3,000 | 418,782 | +1% | +$3,180 | |||||
| D | 2023-10-26 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale+OE | $5.63 | -3,000 | 418,782 | -1% | -$16,885 | |||||
2023-10-17 | RXRX | Borgeson Blake | Dir | S - Sale | $6.58 | -8,885 | 7,425,190 | 0% | -$58,483 | ||||||
| D | 2023-10-16 | RXRX | Virani Shafique | Chief Business Officer | M - OptEx | $2.22 | +18,000 | 140,351 | +15% | +$39,960 | |||||
| D | 2023-10-16 | RXRX | Virani Shafique | Chief Business Officer | S - Sale+OE | $6.30 | -18,000 | 140,351 | -11% | -$113,400 | |||||
| DM | 2023-10-10 | RXRX | Secora Michael | CFO | M - OptEx | $2.22 | +75,000 | 913,186 | +9% | +$166,500 | |||||
| DM | 2023-10-10 | RXRX | Secora Michael | CFO | S - Sale+OE | $6.96 | -50,000 | 913,186 | -5% | -$348,075 | |||||
| D | 2023-10-04 | RXRX | Gibson Christopher | CEO | M - OptEx | $2.48 | +31,250 | 842,747 | +4% | +$77,500 | |||||
| D | 2023-10-04 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $7.21 | -59,794 | 842,747 | -7% | -$431,025 | |||||
2023-10-03 | RXRX | Borgeson Blake | Dir | S - Sale | $7.29 | -8,885 | 7,434,075 | 0% | -$64,778 | ||||||
| D | 2023-09-28 | RXRX | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +3,000 | 418,782 | +1% | +$3,180 | |||||
| D | 2023-09-28 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale+OE | $7.72 | -3,000 | 418,782 | -1% | -$23,159 | |||||
2023-09-19 | RXRX | Borgeson Blake | Dir | S - Sale | $8.36 | -8,885 | 7,442,960 | 0% | -$74,278 | ||||||
| D | 2023-09-15 | RXRX | Virani Shafique | Chief Business Officer | M - OptEx | $2.22 | +18,000 | 140,351 | +15% | +$39,960 | |||||
| D | 2023-09-15 | RXRX | Virani Shafique | Chief Business Officer | S - Sale+OE | $8.66 | -18,000 | 140,351 | -11% | -$155,880 | |||||
| DM | 2023-09-12 | RXRX | Secora Michael | CFO | M - OptEx | $2.22 | +75,000 | 888,186 | +9% | +$166,500 | |||||
| DM | 2023-09-12 | RXRX | Secora Michael | CFO | S - Sale+OE | $8.56 | -50,000 | 888,186 | -5% | -$427,950 | |||||
| D | 2023-09-06 | RXRX | Gibson Christopher | CEO | M - OptEx | $2.48 | +31,250 | 871,291 | +4% | +$77,500 | |||||
| D | 2023-09-06 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $8.81 | -58,765 | 871,291 | -6% | -$517,442 | |||||
2023-09-05 | RXRX | Borgeson Blake | Dir | S - Sale | $8.79 | -8,885 | 7,451,845 | 0% | -$78,136 | ||||||
| D | 2023-08-24 | RXRX | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +3,000 | 418,782 | +1% | +$3,180 | |||||
| D | 2023-08-24 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale+OE | $8.66 | -3,000 | 418,782 | -1% | -$25,968 | |||||
2023-08-22 | RXRX | Borgeson Blake | Dir | S - Sale | $8.91 | -8,885 | 7,460,730 | 0% | -$79,181 | ||||||
| D | 2023-08-15 | RXRX | Virani Shafique | Chief Business Officer | M - OptEx | $2.22 | +18,000 | 140,351 | +15% | +$39,960 | |||||
| D | 2023-08-15 | RXRX | Virani Shafique | Chief Business Officer | S - Sale+OE | $9.25 | -18,000 | 140,351 | -11% | -$166,500 | |||||
| DM | 2023-08-15 | RXRX | Secora Michael | CFO | M - OptEx | $2.22 | +75,000 | 863,186 | +10% | +$166,500 | |||||
| DM | 2023-08-15 | RXRX | Secora Michael | CFO | S - Sale+OE | $9.09 | -50,000 | 863,186 | -5% | -$454,310 | |||||
2023-08-08 | RXRX | Borgeson Blake | Dir | S - Sale | $11.16 | -17,770 | 7,469,615 | 0% | -$198,283 | ||||||
| D | 2023-08-02 | RXRX | Gibson Christopher | CEO | M - OptEx | $4.42 | +39,924 | 890,719 | +5% | +$176,384 | |||||
| D | 2023-08-02 | RXRX | Gibson Christopher | CEO | S - Sale+OE | $13.04 | -65,015 | 890,719 | -7% | -$847,712 | |||||
| D | 2023-07-27 | RXRX | Larson Tina Marriott | Pres, COO | M - OptEx | $1.06 | +8,000 | 424,160 | +2% | +$8,480 | |||||
| D | 2023-07-27 | RXRX | Larson Tina Marriott | Pres, COO | S - Sale+OE | $13.62 | -8,000 | 424,160 | -2% | -$108,994 | |||||
| DM | 2023-07-25 | RXRX | Virani Shafique | Chief Business Officer | M - OptEx | $2.22 | +40,000 | 143,954 | +38% | +$88,800 | |||||
| DM | 2023-07-25 | RXRX | Virani Shafique | Chief Business Officer | S - Sale+OE | $14.36 | -40,000 | 143,954 | -22% | -$574,200 | |||||
2023-07-25 | RXRX | Borgeson Blake | Dir | S - Sale | $14.61 | -18,719 | 7,487,385 | 0% | -$273,464 | ||||||
| DM | 2023-07-18 | RXRX | Secora Michael | CFO | M - OptEx | $2.22 | +75,000 | 842,913 | +10% | +$166,500 | |||||
| DM | 2023-07-18 | RXRX | Secora Michael | CFO | S - Sale+OE | $14.58 | -50,000 | 842,913 | -6% | -$729,150 | |||||
| DM | 2023-07-17 | RXRX | Virani Shafique | Chief Business Officer | M - OptEx | $2.22 | +60,000 | 143,954 | +71% | +$133,200 | |||||
| DM | 2023-07-17 | RXRX | Virani Shafique | Chief Business Officer | S - Sale+OE | $12.73 | -60,000 | 143,954 | -29% | -$763,800 | |||||
| D | 2023-07-12 | RXRX | Gibson Christopher | CEO | M - OptEx | $2.48 | +31,250 | 915,810 | +4% | +$77,500 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |